Literature DB >> 22311853

Cardiac involvement in muscular dystrophy: advances in diagnosis and therapy.

Ali Yilmaz1, Udo Sechtem.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22311853     DOI： 10.1136/heartjnl-2011-300254

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  22 in total

Review 1.  Cardiomyopathy in becker muscular dystrophy: Overview.

Authors:  Rady Ho; My-Le Nguyen; Paul Mather
Journal:  World J Cardiol       Date:  2016-06-26

Review 2.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management.

Authors:  David J Birnkrant; Katharine Bushby; Carla M Bann; Susan D Apkon; Angela Blackwell; David Brumbaugh; Laura E Case; Paula R Clemens; Stasia Hadjiyannakis; Shree Pandya; Natalie Street; Jean Tomezsko; Kathryn R Wagner; Leanne M Ward; David R Weber
Journal:  Lancet Neurol       Date:  2018-02-03       Impact factor: 44.182

3.  Cardiac pathologies in female carriers of Duchenne muscular dystrophy assessed by cardiovascular magnetic resonance imaging.

Authors:  Juliane Schelhorn; Anne Schoenecker; Ulrich Neudorf; Haemi Schemuth; Felix Nensa; Kai Nassenstein; Michael Forsting; Ulrike Schara; Thomas Schlosser
Journal:  Eur Radiol       Date:  2015-03-20       Impact factor: 5.315

4.  SNTA1 gene rescues ion channel function and is antiarrhythmic in cardiomyocytes derived from induced pluripotent stem cells from muscular dystrophy patients.

Authors:  Eric N Jimenez-Vazquez; Michael Arad; Álvaro Macías; Maria L Vera-Pedrosa; Francisco Miguel Cruz; Lilian K Gutierrez; Ashley J Cuttita; André Monteiro da Rocha; Todd J Herron; Daniela Ponce-Balbuena; Guadalupe Guerrero-Serna; Ofer Binah; Daniel E Michele; José Jalife
Journal:  Elife       Date:  2022-06-28       Impact factor: 8.713

5.  Blunted cardiac beta-adrenergic response as an early indication of cardiac dysfunction in Duchenne muscular dystrophy.

Authors:  Ying Li; Shuai Zhang; Xiaoying Zhang; Jing Li; Xiaojie Ai; Li Zhang; Daohai Yu; Shuping Ge; Yizhi Peng; Xiongwen Chen
Journal:  Cardiovasc Res       Date:  2014-05-08       Impact factor: 10.787

Review 6.  Cardiac phenotype of Duchenne Muscular Dystrophy: insights from cellular studies.

Authors:  Natalia Shirokova; Ernst Niggli
Journal:  J Mol Cell Cardiol       Date:  2012-12-20       Impact factor: 5.000

7.  Clinical application of an NGS-based method in the preimplantation genetic testing for Duchenne muscular dystrophy.

Authors:  Yixin Ren; Ying Lian; Zhiqiang Yan; Fan Zhai; Ming Yang; Xiaohui Zhu; Yuqian Wang; Yanli Nie; Shuo Guan; Ying Kuo; Jin Huang; Xiaodan Shi; Jialin Jia; Jie Qiao; Liying Yan
Journal:  J Assist Reprod Genet       Date:  2021-03-15       Impact factor: 3.357

Review 8.  Autonomic dysfunction in muscular dystrophy: a theoretical framework for muscle reflex involvement.

Authors:  Scott A Smith; Ryan M Downey; Jon W Williamson; Masaki Mizuno
Journal:  Front Physiol       Date:  2014-02-18       Impact factor: 4.566

9.  Left ventricular systolic function and the pattern of late-gadolinium-enhancement independently and additively predict adverse cardiac events in muscular dystrophy patients.

Authors:  Anca Florian; Anna Ludwig; Markus Engelen; Johannes Waltenberger; Sabine Rösch; Udo Sechtem; Ali Yilmaz
Journal:  J Cardiovasc Magn Reson       Date:  2014-09-25       Impact factor: 5.364

10.  Cardioprotective effect of nicorandil on isoproterenol induced cardiomyopathy in the Mdx mouse model.

Authors:  Rachel T Sullivan; Ngoc T Lam; Margaret Haberman; Margaret J Beatka; Muhammad Z Afzal; Michael W Lawlor; Jennifer L Strande
Journal:  BMC Cardiovasc Disord       Date:  2021-06-15       Impact factor: 2.298
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.